Assessing the Safety of Dapivirine Gel and Film Formulations
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This is a study to determine the safety of dapivirine gel and dapvirine film for healthy,
HIV-uninfected women aged 18-45 years using the product for 7 daily doses.